These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30753336)

  • 1. Kras-driven heterotopic tumor development from hepatobiliary organoids.
    Ochiai M; Yoshihara Y; Maru Y; Matsuura T; Izumiya M; Imai T; Hippo Y
    Carcinogenesis; 2019 Sep; 40(9):1142-1152. PubMed ID: 30753336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids.
    Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Yao R; Noda T; Itami M; Hippo Y
    J Pathol; 2021 Oct; 255(2):177-189. PubMed ID: 34184756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition.
    Maru Y; Tanaka N; Tatsumi Y; Nakamura Y; Itami M; Hippo Y
    Oncogenesis; 2021 Jun; 10(6):46. PubMed ID: 34172714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
    Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortcuts to intestinal carcinogenesis by genetic engineering in organoids.
    Maru Y; Onuma K; Ochiai M; Imai T; Hippo Y
    Cancer Sci; 2019 Mar; 110(3):858-866. PubMed ID: 30637899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
    Chiorean EG; Ramasubbaiah R; Yu M; Picus J; Bufill JA; Tong Y; Coleman N; Johnston EL; Currie C; Loehrer PJ
    Oncologist; 2012; 17(1):13. PubMed ID: 22210086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis.
    Matsuura T; Maru Y; Izumiya M; Hoshi D; Kato S; Ochiai M; Hori M; Yamamoto S; Tatsuno K; Imai T; Aburatani H; Nakajima A; Hippo Y
    Carcinogenesis; 2020 Jun; 41(4):490-501. PubMed ID: 31233118
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
    Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma.
    Cristinziano G; Porru M; Lamberti D; Buglioni S; Rollo F; Amoreo CA; Manni I; Giannarelli D; Cristofoletti C; Russo G; Borad MJ; Grazi GL; Diodoro MG; Giordano S; Sacconi A; Forcato M; Anastasi S; Leonetti C; Segatto O
    J Hepatol; 2021 Aug; 75(2):351-362. PubMed ID: 33741397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy.
    Lin YK; Fang Z; Jiang TY; Wan ZH; Pan YF; Ma YH; Shi YY; Tan YX; Dong LW; Zhang YJ; Wang HY
    Cancer Lett; 2018 May; 421():161-169. PubMed ID: 29452147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
    Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
    Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
    Green S; Trejo CL; McMahon M
    Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision modeling of gall bladder cancer patients in mice based on orthotopic implantation of organoid-derived tumor buds.
    Kato S; Fushimi K; Yabuki Y; Maru Y; Hasegawa S; Matsuura T; Kurotaki D; Suzuki A; Kobayashi N; Yoneda M; Higurashi T; Enaka M; Tamura T; Hippo Y; Nakajima A
    Oncogenesis; 2021 Apr; 10(4):33. PubMed ID: 33866327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell of origin in biliary tract cancers and clinical implications.
    Moeini A; Haber PK; Sia D
    JHEP Rep; 2021 Apr; 3(2):100226. PubMed ID: 33665585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of hepatobiliary organoids from human induced pluripotent stem cells.
    Wu F; Wu D; Ren Y; Huang Y; Feng B; Zhao N; Zhang T; Chen X; Chen S; Xu A
    J Hepatol; 2019 Jun; 70(6):1145-1158. PubMed ID: 30630011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kras
    Chung WC; Wang J; Zhou Y; Xu K
    Oncoscience; 2017 Sep; 4(9-10):131-138. PubMed ID: 29142904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas.
    Lódi C; Szabó E; Holczbauer A; Batmunkh E; Szíjártó A; Kupcsulik P; Kovalszky I; Paku S; Illyés G; Kiss A; Schaff Z
    Mod Pathol; 2006 Mar; 19(3):460-9. PubMed ID: 16439986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma.
    De Crignis E; Hossain T; Romal S; Carofiglio F; Moulos P; Khalid MM; Rao S; Bazrafshan A; Verstegen MM; Pourfarzad F; Koutsothanassis C; Gehart H; Kan TW; Palstra RJ; Boucher C; IJzermans JN; Huch M; Boj SF; Vries R; Clevers H; van der Laan LJ; Hatzis P; Mahmoudi T
    Elife; 2021 Jul; 10():. PubMed ID: 34328417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.